- Report
- November 2022
- 276 Pages
Global
From €3553EUR$3,750USD£2,999GBP
- Report
- September 2023
- 90 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- September 2023
- 84 Pages
Global
From €4691EUR$4,950USD£3,958GBP
- Report
- August 2022
- 46 Pages
Global
From €4691EUR$4,950USD£3,958GBP
- Report
- November 2023
- 200 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- November 2022
- 117 Pages
Global
From €4691EUR$4,950USD£3,958GBP
- Report
- March 2022
- 82 Pages
Global
From €4691EUR$4,950USD£3,958GBP
- Report
- December 2023
- 137 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- August 2022
Global
From €938EUR$990USD£792GBP
- Report
- August 2022
Global
From €938EUR$990USD£792GBP
- Report
- August 2022
Global
From €938EUR$990USD£792GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- August 2022
Global
From €749EUR$790USD£632GBP
- Report
- February 2024
- 110 Pages
North America
From €4501EUR$4,750USD£3,799GBP
- Report
- November 2023
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- November 2023
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP
- Report
- November 2023
- 30 Pages
Global
From €3080EUR$3,250USD£2,599GBP

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities.
The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more